Research
Molecular
SCD1 inhibitors have been developed to treat various types of cancer.
SCD1 inhibitors could be a promising avenue for cancer therapy.
StrongSupportsmedium confidence
Potent SCD1 inhibitors have been developed to treat various types of cancer.
Why this rating
The abstract discusses advancements in SCD1 inhibitor development.
Source
SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
Qin Sun et al. · Biomedicine & Pharmacotherapy · 2023
DOI 10.1016/j.biopha.2023.115586
reviewCited 101×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →